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To determine whether guinea pigs are infected with in-
ﬂ  uenza virus in nature, we conducted a serologic study in 
domestic guinea pigs in Ecuador. Detection of antibodies 
against inﬂ  uenza A and B raises the question about the role 
of guinea pigs in the ecology and epidemiology of inﬂ  uenza 
virus in the region.
I
nﬂ  uenza A virus infection causes disease in humans and 
domestic animals, including pigs, horses, and chickens, 
and seasonal epidemics among humans in the Northern and 
Southern Hemispheres result in hospitalizations and deaths 
worldwide. Inﬂ  uenza A virus transmission studies are of-
ten conducted in laboratory guinea pigs (1,2) because the 
virus can efﬁ  ciently spread from infected animals to naive 
guinea pigs by direct and indirect (short-range infectious 
aerosols) contact (3,4). However, whether guinea pigs are 
naturally infected with inﬂ  uenza virus outside the labora-
tory setting is not known.
In some regions of South America, guinea pigs are 
part of the traditional cuisine and are produced as livestock 
and sold commercially for human consumption. Guinea 
pigs are customarily raised on small rural farms in prox-
imity to other livestock. Circulation of inﬂ  uenza virus in 
these populations has not been studied. Given the effect of 
inﬂ  uenza virus on human health and the susceptibility of 
guinea pigs to inﬂ  uenza virus infection in the laboratory, 
it is worthwhile to determine whether inﬂ  uenza virus can 
spread among guinea pigs in agricultural settings. As an 
initial step in this endeavor, we obtained serum samples 
from domestic guinea pigs in Ecuador and tested them for 
the presence of inﬂ  uenza antibodies to determine whether 
the guinea pigs had been infected with inﬂ  uenza virus.
The Study
We obtained serum samples from 40 guinea pigs from 
3 different regions of Ecuador (Figure 1), 20 from Cuenca 
and 10 each from Guayaquil and the Manabí region. Cuenca 
is located in the Andes region, 2,500 m above sea level; it is 
one of the main producers of guinea pig meat. Guayaquil, 
the most populated city in Ecuador, is located at the head 
of the Gulf of Guayaquil on the Paciﬁ  c Ocean. The Manabí 
region is located in western Ecuador on the Paciﬁ  c Ocean 
coast. Serum samples were collected from adult guinea 
pigs that we purchased from local farms (Cuenca), where 
they had been raised as livestock, or from live animal mar-
kets (Guayaquil and Manabí). The samples were collected 
by heart puncture under general anesthesia (combination 
of ketamine and xylazine). Animals were euthanized after 
samples were obtained.
For antigens in the serologic analyses, we used whole 
viruses and recombinant hemagglutinin, nucleoprotein, and 
neuraminidase (subtypes N1 and N2) proteins produced in 
our laboratory as described (5,6). The whole viruses were 
A/Brisbane/59/2007 (H1N1) (Brisbane07), A/New Cale-
donia/20/1999 (H1N1) (Newcal99), A/Wisconsin/67/2005 
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Figure 1. Three regions of Ecuador where guinea pig serum 
samples were obtained: Cuenca, Guayaquil, and Manabi. The 
country is bordered by Colombia to the north, Peru to the east and 
south, and the Paciﬁ  c Ocean to the west. Cuenca is located in the 
Andes; the average annual mean temperature is 14.7°C, and the 
average annual relative humidity is 85%. Guayaquil is located at 
the head of the Gulf of Guayaquil; the mean temperature is 26.1°C, 
and relative humidity is 74%. The Manabí region is located on the 
Paciﬁ  c Ocean coast; the mean temperature is 25.9°C, and relative 
humidity is 79%.(H3N2) (Wisconsin05), A/Vietnam/1203/2004 (H5N1) 
(Vietnam04), and B/Yamagata/16/1988 (Yamagata88). The 
hemagglutinins were A/California/04/2009 (Cal09), New-
Cal99, Vietnam04, Wisconsin05, and Yamagata88. The 
nucleoproteins were Brisbane07, A/Puerto Rico/08/1934, 
and B/Florida/04/2006. The subtype N1 neuraminidases 
were Cal09 and Vietnam04; the N2 subtype was A/Hong 
Kong/1/1968.
ELISA was done as described (7), with slight modiﬁ  -
cations for the use of guinea pig serum. The cutoff for se-
rum considered positive for inﬂ  uenza virus was the value of 
the negative control (naive guinea pig serum) +3 SD (from 
3 repetitions). For Western blot (WB) analyses (8), serum 
samples were pooled into groups of 5 (groups 1–4, 5–6, and 
7–8 were from Cuenca, Guayaquil, and Manabí region, re-
spectively). Pooled samples were also used for the hemag-
glutination inhibition (HI) assay, as described (9), using in-
ﬂ  uenza strains Brisbane07, Wisconsin05, and Vietnam04. 
As positive controls, we used serum from guinea pigs that 
we had infected with Cal09, Brisbane07, NewCal99, Wis-
consin05, Vietnam04, or Yamagata88.
ELISA results for the 40 serum samples showed that 
20, 18, and 14 were positive for inﬂ  uenza subtypes H1, H3, 
and H5, respectively (Table 1). The samples were also test-
ed for the presence of antibodies against the inﬂ  uenza virus 
nucleoprotein: results for 29 were positive. Samples with 
positive results to >1 hemagglutinin antigens and to nucleo-
protein were also analyzed for the presence of antibodies 
against proteins of the neuraminidase subtypes N1 (Cal09, 
Vietnam04) and N2 (inﬂ   uenza A/Hong Kong/1/1968 
[H3N2]) (Table 1). Serum samples were also tested for the 
presence of inﬂ  uenza B virus by using whole virus, recom-
binant hemagglutinin, and recombinant nucleoprotein as 
described above. Samples from Cuenca showed the highest 
overall positivity to the 3 antigens (Table 2). 
WB analysis of pooled samples from the 3 areas con-
ﬁ  rmed the ELISA results that showed antibodies against 
the hemagglutinin and nucleoprotein antigens; however, 
samples from Manabí region (7,8) showed immunoreactiv-
ity to the H3 antigen only (Figure 2). WB results for serum 
samples from Cuenca and Guayaquil were positive for in-
ﬂ  uenza B virus, but results were not positive for samples 
from Manabí when whole virus was used as antigen (Figure 
2). HI activity was observed in all pooled samples against 
all 3 viruses tested. Titers were highest in samples from 
Cuenca (320 for Brisbane07, 640 for Wisconsin05, and 80 
for Vietnam04) and lowest for samples from Manabí (80 
for Brisbane07 and 40 for Wisconsin05 and Vietnam04). 
Titers for samples from Guayaquil were 160 for Brisbane07 
and 80 for Wisconsin05 and Vietnam04.
Conclusions
We showed the presence of inﬂ  uenza virus antibodies 
with HI activity to different virus subtypes in guinea pigs 
marketed through local farms and live animal markets in dif-
ferent regions of Ecuador. Seroprevalence was similar for 
inﬂ  uenza A virus subtypes H1 (50%) and H3 (45%). A study 
of inﬂ  uenza among humans in Ecuador also showed similar 
seroprevalences for subtypes H1 (5.1%) and H3 (5.5%) (10). 
This10-fold difference between seroprevalence rates among 
humans and the guinea pigs in our study may be explained 
by animal husbandry practices that facilitate inﬂ  uenza trans-
mission (e.g., the crowding of animals in cages).
The presence of antibodies to inﬂ  uenza B virus in guin-
ea pigs is notable because infection with this virus is thought 
to be restricted to humans (11). Recent studies in our labora-
tory demonstrated that guinea pigs can also be infected with 
inﬂ  uenza B viruses and that they readily transmit the virus 
to naive guinea pigs (12). These studies support our ﬁ  nd-
ing that inﬂ  uenza B virus has the potential to be transmitted 
from humans to other species. Further studies are needed to 
isolate and characterize the type B inﬂ  uenza virus present in 
the population of guinea pigs to determine if there has been 
an adaptation to the new host or if the guinea pig is only a 
transient reservoir for the human virus.
We found that several guinea pigs had antibodies against 
inﬂ  uenza A (H5). Ecuador is purported to be free of avian in-
ﬂ  uenza (13); however, reports from other countries in South 
America demonstrate the presence of avian subtypes H3, 
H5N2, H7N3, and H13N9 in wild birds (14). In addition, 
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Table 1. ELISA results for the presence of influenza A virus antibodies in guinea pigs from different regions of Ecuador* 
Region 
No. (%) positive, by antigen† 
H1 H3 H5 NP N1 (Cal09)  N1 (Vietnam04)  N2
Cuenca, n = 20  11 (55)  12 (60)  6 (30)  16 (80)  8 (57)‡  8 (57)‡  10 (71) 
Guayaquil, n = 10  8 (80)  5 (50)  8 (80)  10 (100)  8 (88)§  8 (88)§  8 (88)§ 
Manabí, n = 10  1 (10)  1 (10)  0   3 (30)  1 (50)¶  1 (50)¶  0¶ 
Total  20 18  14 29  17  17  18 
*Samples were from adult guinea pigs raised as livestock on local farms (Cuenca) or from live animal markets (Guayaquil and Manabí). H1, recombinant 
hemagglutinin from A/California/04/2009 (Cal09); H3, recombinant hemagglutinin from A/Wisconsin/67/2005; H5, recombinant hemagglutinin from 
A/Vietnam/1203/2004 (Vietnam04); NP, recombinant nucleoprotein from A/Brisbane/10/2007; N1, recombinant neuraminidase from Cal09 or Vietnam04; 
N2, recombinant neuraminidase from A/Hong Kong/1/1968. 
†Serum samples were considered positive if absorbance (read at 405 nm) was higher than the value of the negative control (naive guinea pig serum) +3 
SD.
‡Only 14 samples were tested. 
§Only 9 samples were tested. 
¶Only 2 samples were tested.  Inﬂ  uenza Virus Infection in Guinea Pigs
chickens, turkeys, and guinea pigs that are later sold in local 
farmers’ markets are raised together by some families, there-
by facilitating contact of guinea pigs with avian inﬂ  uenza 
viruses. We tested only for seroreactivity to the H5 hemag-
glutinin and the N1 neuraminidase; therefore, further studies 
are needed to determine whether different avian origin inﬂ  u-
enza viruses are present in the guinea pig population.
We did not determine whether guinea pigs are an in-
cidental host for inﬂ  uenza virus infection or, if instead, the 
virus has been adapted to these animals or if guinea pigs are 
a natural reservoir for some inﬂ  uenza viruses. To this end, 
virus isolation and characterization would be necessary to 
determine the virus strains circulating in this population. 
In the laboratory, guinea pigs are infected and efﬁ  ciently 
transmit inﬂ  uenza viruses to naive hosts without showing 
any overt clinical signs of disease (1). Therefore, further 
studies are needed to address the speciﬁ  c role of guinea 
pigs raised as livestock in the ecology and epidemiology of 
inﬂ  uenza viruses in the region.
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Table 2. ELISA results for the presence of influenza B virus antibodies in guinea pigs from different regions of Ecuador* 
Region 
No. (%) positive, by antigen† 
Whole virus (Yamagata88)   Recombinant hemagglutinin   Recombinant nucleoprotein 
Cuenca, n = 20  17 (85)  18 (90)  18 (94)‡ 
Guayaquil, n = 10  8 (80)  9 (90)  9 (90) 
Manabí, n =10  2 (20)  1 (1)  1 (10) 
Total   27  28  28 
*Samples were from adult guinea pigs raised as livestock on local farms (Cuenca) or from live animal markets (Guayaquil and Manabí). Whole virus, 
B/Yamagata/16/1988. Recombinant hemagglutinin was derived from B/Florida/04/2006; nucleoprotein was derived from B/Yamagata/16/1988. 
†Serum samples were considered positive if absorbance (read at 405 nm) was higher than the value of the negative control (naive guinea pig serum) + 3 
SD.
‡Only 19 samples were tested. 
Figure 2. Results of Western blot analyses of pooled serum samples from adult guinea pigs in Ecuador. The guinea pigs were obtained 
from farms in Cuenca, where they had been raised as livestock, or from live animal markets in Guayaquil and Manabí. The results 
show different inﬂ  uenza antigens: recombinant hemagglutinin (rHA) A/New Caledonia/20/1999 (A); rHA A/Wisconsin/67/2005 (B); rHA 
A/Vietnam/1203/2004 (C); recombinant nucleoprotein A/Puerto Rico/08/1934 (D); and B virus (whole virus B/Yamagata/16/1988) (E). 
Molecular weights are shown at left. (+), serum from guinea pigs infected in the laboratory with inﬂ  uenza virus; (−), serum from naive 
guinea pig; lanes 1–4, pooled serum samples from Cuenca; lanes 5–6, pooled serum samples from Guayaquil; lanes 7–8, pooled serum 
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